Clinical Trial: Mesalamine for Uncomplicated Diverticular Disease: a Randomized, Double-blind, Placebo-controlled Study
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Double-blind, Randomised, Placebo-controlled, Parallel-group, Multi-centre Phase III Clinical Study on the Efficacy and Tolerability of Mesalazine Pellets vs. Placebo in Diverticular Disease
Brief Summary: The purpose of this study is to determine whether mesalamine is effective in the treatment of uncomplicated diverticular disease by reducing the pain.
Detailed Summary:
Sponsor: Dr. Falk Pharma GmbH
Current Primary Outcome: The change in intensity of lower abdominal pain during the first four weeks of treatment (SPID 0-28) [ Time Frame: 4 weeks ]
Original Primary Outcome: Change in intensity of lower abdominal pain during the first four weeks of treatment [ Time Frame: 4 weeks ]
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Dr. Falk Pharma GmbH
Dates:
Date Received: June 21, 2012
Date Started: May 2002
Date Completion:
Last Updated: January 20, 2016
Last Verified: January 2016